This is the classic website, which will be retired eventually. Please visit the modernized instead.

Key Record Dates Identifier: NCT06103864
Brief Title: A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer

First Submitted : October 23, 2023
First Submitted that Met QC Criteria : October 23, 2023
First Posted : October 27, 2023

Last Update Submitted that Met QC Criteria : April 18, 2024
Last Update Posted : April 19, 2024 (Estimate)